NOTCH1 and acute myeloid leukemia: In addition, one hundred de novo AML patients showed a greater gene expression of NOTCH1, JAG1 and DLL1 compared to normal donors, and a greater expression of these genes was an adverse predictor factor in the multivariate analysis [45].